A Phase II single-arm trial to investigate tepotinib in stage IIIB/IV adenocarcinoma of the lung with MET exon 14 (METex14) skipping alterations after failure of at least one prior active therapy, including a platinum-doublet-containing regimen

Type of Cancer
Lung

Site
Hackensack

Sponsor
EMD Serono

Protocol Number
MS200095-0022

To Learn More Call
201-510-0910